The abstracts of the CTAD are available in PDF format, you can download them on
this link
The abstracts of the ICFSR are available in PDF format, you can download them on this link
this link
The abstracts of the ICFSR are available in PDF format, you can download them on this link
this link
In this manuscript, we have synthesized the literature reviews and meta-analyses relating to modifiable risk factors associated with AD. Article M. Rochoy (1) M. Rochoy, V. Rivas, E. Chazard, E. Decarpentry, G. Saudemont, P.-A. Hazard, F. Puisieux, S. Gautier, R…. Continue Reading →
The 2018 Clinical Trials on Alzheimer’s Disease (CTAD) conference showcased recent successes and failures in trials of Alzheimer’s disease treatments. Article B. Vellas (CTAD)
Background: Drug development for disease modifying agents in Alzheimer’s disease (AD) is focused increasingly on targeting underlying pathology in very early stages of AD or in cognitively normal patients at elevated risk of developing dementia due to Alzheimer’s. Very early… Continue Reading →
© 2024 Aging-news
